Multi-omics analyses identify PREPL as a key regulator of protein trafficking, a pathway underlying Alzheimer's disease pathogenesis

¹Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, United States
²Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, United States
³Department of Pharmacology & Systems Therapeutics, Mount Sinai School of Medicine, United States
⁴Weill Graduate School of Medical Sciences, United States
⁵National Institute of Health, United States
⁶Department of Biomedical Sciences, Cooper Medical School of Rowan University, United States
⁷Department of Pharmacological Sciences, Mount Sinai School of Medicine, United States
⁸Icahn School of Medicine at Mount Sinai, United States
⁹Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, United States

↵* Corresponding Author:
Lakshmi A. Devi, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, 1984 Annenberg Building, Box 1603, New York, New York, 10029, United States. E-mail: lakshmi.devi{at}mssm.edu
* Corresponding Author; email: bin.zhang{at}mssm.edu